Skip to main content

Table 2 Association between individual MetS component and coronary parameters according to diabetes status

From: Differential association between metabolic syndrome and coronary artery disease evaluated with cardiac computed tomography according to the presence of diabetes in a symptomatic Korean population

Characteristic

n

Any plaque

Obstructive plaque

CACS >100

  

OR (95% CI)

OR (95% CI)

OR (95% CI)

No diabetes

2308

   

Obesity

    

No

1383

1.00

1.00

1.00

Yes

925

1.27 (1.05–1.55) ‡

1.20 (0.91–1.59)

1.19 (0.88–1.62)

Increased blood pressure

    

No

664

1.00

1.00

1.00

Yes

1644

1.25 (1.01–1.55)‡

1.59 (1.14–2.23)†

1.27 (0.89–1.81)

Increased triglycerides

    

No

1522

1.00

1.00

1.00

Yes

786

1.37 (1.12–1.68)†

1.56 (1.18–2.06)†

1.18 (0.87–1.62)

Decreased HDL

    

No

1616

1.00

1.00

1.00

Yes

692

1.35 (1.09–1.68)†

1.55 (1.14–2.10)†

1.57 (1.12–2.19)†

Increased fasting glucose

    

No

1640

1.00

1.00

1.00

Yes

668

1.22 (0.99–1.50)

0.97 (0.72–1.31)

1.24 (0.90–1.69)

Type 2 diabetes

561

   

Obesity

    

No

288

1.00

1.00

1.00

Yes

273

1.27 (0.85–1.90)

0.86 (0.57–1.31)

1.12 (0.72–1.75)

Increased blood pressure

    

No

140

1.00

1.00

1.00

Yes

421

1.03 (0.65–1.63)

0.76 (0.48–1.21)

1.11 (0.66–1.86)

Increased triglycerides

    

No

315

1.00

1.00

1.00

Yes

246

1.34 (0.89–2.02)

1.00 (0.65–1.53)

0.93 (0.59–1.47)

Decreased HDL

    

No

347

1.00

1.00

1.00

Yes

214

0.92 (0.60–1.40)

1.44 (0.93–2.24)

1.13 (0.70–1.82)

  1. All models are adjusted for age, sex, current smoking, LDL, and GFR. CACS, coronary artery calcium score; CI, confidence intervals; GFR, glomerular filtration rate; HDL, high-density lipoprotein; LDL, low-density lipoprotein, MetS, metabolic syndrome; OR, odds ratios. *P <0.001; †P <0.01; ‡P <0.05.